Laboratory Animal and Comparative Medicine ›› 2022, Vol. 42 ›› Issue (2): 146-151.DOI: 10.12300/j.issn.1674-5817.2021.088
• Animal Models of Human Diseases • Previous Articles Next Articles
Xun WEI1(
), Xia JIANG2, Yuxuan ZHENG1, Lewen ZHANG1, Zhengyu ZHOU1(
)
Received:2021-04-26
Revised:2021-12-17
Online:2022-04-25
Published:2022-04-25
Contact:
Zhengyu ZHOU
CLC Number:
Xun WEI,Xia JIANG,Yuxuan ZHENG,et al. Progress of Pancreatic Stellate Cells in Research of Pancreatic Disease Model[J]. Laboratory Animal and Comparative Medicine, 2022, 42(2): 146-151. DOI: 10.12300/j.issn.1674-5817.2021.088.
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.slarc.org.cn/dwyx/EN/10.12300/j.issn.1674-5817.2021.088
| 1 | 凤振宁, 金世柱. 急性胰腺炎动物模型构建方法的研究[J]. 胃肠病学和肝病学杂志, 2020, 29(4):388-391. DOI:10.3969/j.issn. 1006-5709.2020.04.006 . |
| 2 | PANG T C Y, WILSON J S, APTE M V. Pancreatic stellate cells: what's new? [J]. Curr Opin Gastroenterol, 2017, 33(5):366-373. DOI:10.1097/MOG.0000000000000378 . |
| 3 | BYNIGERI R R, JAKKAMPUDI A, JANGALA R, et al. Pancreatic stellate cell: Pandora's box for pancreatic disease biology[J]. World J Gastroenterol, 2017, 23(3):382-405. DOI:10.3748/wjg.v23.i3.382 . |
| 4 | SHERMAN M H. Stellate cells in tissue repair, inflammation, and cancer[J]. Annu Rev Cell Dev Biol, 2018, 34:333-355. DOI:10.1146/annurev-cellbio-100617-062855 . |
| 5 | OMARY M B, LUGEA A, LOWE A W, et al. The pancreatic stellate cell: a star on the rise in pancreatic diseases[J]. J Clin Invest, 2007, 117(1):50-59. DOI: 10.1172/JCI30082 . |
| 6 | LI W, LIU H, QIAN W K, et al. Hyperglycemia aggravates microenvironment hypoxia and promotes the metastatic ability of pancreatic cancer[J]. Comput Struct Biotechnol J, 2018, 16:479-487. DOI:10.1016/j.csbj.2018.10.006 . |
| 7 | HUANG Q, HUANG M, MENG F, et al. Activated pancreatic stellate cells inhibit NK cell function in the human pancreatic cancer microenvironment[J]. Cell Mol Immunol, 2019, 16(1):87-89. DOI:10.1038/s41423-018-0014-2 . |
| 8 | APTE M V, HABER P S, APPLEGATE T L, et al. Periacinar stellate shaped cells in rat pancreas: identification, isolation, and culture[J]. Gut, 1998, 43(1):128-133. DOI:10.1136/gut.43.1.128 . |
| 9 | 许小凡, 吴楠, 朱林佳, 等. 昆明小鼠胰腺星状细胞分离培养与鉴定[J]. 新乡医学院学报, 2016, 33(7):564-567. DOI:10.7683/xxyxyxb.2016.07.004 . |
| 10 | MANDALIA A, WAMSTEKER E J, DIMAGNO M J. Recent advances in understanding and managing acute pancreatitis[J]. F1000Research, 2018, 7: F1000 Faculty Rev-F1000 Faculty 959. DOI:10.12688/f1000research.14244.2 . |
| 11 | 杨晶晶, 张丹, 陈嘉屿. 急性胰腺炎动物模型研究进展[J]. 解放军医学杂志, 2019, 44(11):984-990. DOI:10.11855/j.issn.0577-7402.2019.11.16 . |
| 12 | 张林燚, 白明, 苗明三. 基于中西医临床病证特点的急性胰腺炎动物模型分析[J]. 中国实验方剂学杂志, 2021, 27(12):196-201. DOI:10.13422/j.cnki.syfjx.20211104 . |
| 13 | HABTEZION A. Inflammation in acute and chronic pancreatitis[J]. Curr Opin Gastroenterol, 2015, 31(5):395-399. DOI:10.1097/MOG.0000000000000195 . |
| 14 | LIOU G Y, DÖPPLER H, NECELA B, et al. Macrophage-secreted cytokines drive pancreatic acinar-to-ductal Metaplasia through NF-κB and MMPs[J]. J Cell Biol, 2013, 202(3):563-577. DOI:10.1083/jcb.201301001 . |
| 15 | SEMWAL D K, KUMAR A, ASWAL S, et al. Protective and therapeutic effects of natural products against diabetes mellitus via regenerating pancreatic β-cells and restoring their dysfunction[J]. Phytother Res, 2021, 35(3):1218-1229. DOI:10.1002/ptr.6885 . |
| 16 | 江霞, 钱豪杰, 魏迅, 等. 斑马鱼糖尿病模型的构建及应用进展[J]. 实验动物与比较医学, 2020, 40(6):547-552. DOI:10.3969/j.issn.1674-5817.2020.06.016 . |
| 17 | KIM J W, PARK S Y, YOU Y H, et al. Suppression of ROS production by exendin-4 in PSC attenuates the high glucose-induced islet fibrosis[J]. PLoS One, 2016, 11(12):e0163187. DOI:10.1371/journal.pone.0163187 . |
| 18 | KIM J J, LEE E, RYU G R, et al. Hypoxia increases β-cell death by activating pancreatic stellate cells within the islet[J]. Diabetes Metab J, 2020, 44(6):919-927. DOI:10.4093/dmj.2019.0181 . |
| 19 | XU X F, LIU F, XIN J Q, et al. Respective roles of the mitogen-activated protein kinase (MAPK) family members in pancreatic stellate cell activation induced by transforming growth factor-β1 (TGF-β1)[J]. Biochem Biophys Res Commun, 2018, 501(2):365-373. DOI:10.1016/j.bbrc.2018.04.176 . |
| 20 | JIN G H, HONG W L, GUO Y Y, et al. Molecular mechanism of pancreatic stellate cells activation in chronic pancreatitis and pancreatic cancer[J]. J Cancer, 2020, 11(6):1505-1515. DOI:10.7150/jca.38616 . |
| 21 | 宗毅, 廖泉, 赵玉沛. 胰腺癌实验动物模型的建立与应用[J]. 中华实验外科杂志, 2014, 31(1):210-211. DOI:10.3760/cma.j.issn.1001-9030.2014.01.078 . |
| 22 | LEE J W, KOMAR C A, BENGSCH F, et al. Genetically engineered mouse models of pancreatic cancer: The KPC model (LSL-KrasG12D/+;LSL-Trp53R172H/+;Pdx-1-Cre), its variants, and their application in immuno-oncology drug discovery[J]. Curr Protoc Pharmacol, 2016, 73:14.39.1-14.39.20. DOI:1002/cpph.2 . |
| 23 | POTHULA S P, XU Z H, GOLDSTEIN D, et al. Key role of pancreatic stellate cells in pancreatic cancer[J]. Cancer Lett, 2016, 381(1):194-200. DOI:10.1016/j.canlet.2015.10.035 . |
| 24 | GARG B, GIRI B, MODI S, et al. NFκB in pancreatic stellate cells reduces infiltration of tumors by cytotoxic T cells and killing of cancer cells, via up-regulation of CXCL12[J]. Gastroenterology, 2018, 155(3):880-891.e8. DOI:10.1053/j.gastro.2018.05.051 . |
| 25 | LI C X, CUI L H, YANG L, et al. Pancreatic stellate cells promote tumor progression by promoting an immunosuppressive microenvironment in murine models of pancreatic cancer[J]. Pancreas, 2020, 49(1):120-127. DOI:10.1097/MPA. 0000000000001464 . |
| 26 | VOGELMANN R, RUF D, WAGNER M, et al. Effects of fibrogenic mediators on the development of pancreatic fibrosis in a TGF-beta1 transgenic mouse model[J]. Am J Physiol Gastrointest Liver Physiol, 2001, 280(1):G164-G172. DOI: 10.1152/ajpgi.2001.280.1.G164 . |
| 27 | LI F F, CHEN B J, LI W, et al. Islet stellate cells isolated from fibrotic islet of goto-kakizaki rats affect biological behavior of beta-cell[J]. J Diabetes Res, 2016, 2016:6924593. DOI:10.1155/2016/6924593 . |
| 28 | OHNISHI H, MIYATA T, YASUDA H, et al. Distinct roles of Smad2-, Smad3-, and ERK-dependent pathways in transforming growth factor-beta1 regulation of pancreatic stellate cellular functions[J]. J Biol Chem, 2004, 279(10):8873-8878. DOI: 10.1074/jbc.M309698200 . |
| 29 | WYNN T A, RAMALINGAM T R. Mechanisms of fibrosis: therapeutic translation for fibrotic disease[J]. Nat Med, 2012, 18(7):1028-1040. DOI:10.1038/nm.2807 . |
| 30 | YANG S S, LIAN G J. ROS and diseases: role in metabolism and energy supply[J]. Mol Cell Biochem, 2020, 467(1-2):1-12. DOI:10.1007/s11010-019-03667-9 . |
| 31 | RENDRA E, RIABOV V, MOSSEL D M, et al. Reactive oxygen species (ROS) in macrophage activation and function in diabetes[J]. Immunobiology, 2019, 224(2):242-253. DOI:10.1016/j.imbio.2018.11.010 . |
| 32 | GERBER P A, RUTTER G A. The role of oxidative stress and hypoxia in pancreatic beta-cell dysfunction in diabetes mellitus[J]. Antioxid Redox Signal, 2017, 26(10):501-518. DOI:10.1089/ars.2016.6755 . |
| 33 | QIN W J, LI C, ZHENG W, et al. Inhibition of autophagy promotes metastasis and glycolysis by inducing ROS in gastric cancer cells[J]. Oncotarget, 2015, 6(37):39839-39854. DOI:10.18632/oncotarget.5674 . |
| 34 | AHMAD W, IJAZ B, SHABBIRI K, et al. Oxidative toxicity in diabetes and Alzheimer's disease: mechanisms behind ROS/RNS generation[J]. J Biomed Sci, 2017, 24(1):76. DOI:10.1186/s12929-017-0379-z . |
| 35 | JAKUBOWSKA M A, FERDEK P E, GERASIMENKO O V, et al. Nitric oxide signals are interlinked with calcium signals in normal pancreatic stellate cells upon oxidative stress and inflammation[J]. Open Biol, 2016, 6(8):160149. DOI:10.1098/rsob.160149 . |
| 36 | SUZUKI K. Chronic inflammation as an immunological abnormality and effectiveness of exercise[J]. Biomolecules, 2019, 9(6):223. DOI:10.3390/biom9060223 . |
| 37 | SHIMIZU K. Pancreatic stellate cells: molecular mechanism of pancreatic fibrosis[J]. J Gastroenterol Hepatol, 2008, 23():S119-S121. DOI:10.1111/j.1440-1746.2007.05296.x . |
| 38 | RAMAKRISHNAN P, LOH W M, GOPINATH S C B, et al. Selective phytochemicals targeting pancreatic stellate cells as new anti-fibrotic agents for chronic pancreatitis and pancreatic cancer[J]. Acta Pharm Sin B, 2020, 10(3):399-413. DOI:10.1016/j.apsb.2019.11.008 . |
| 39 | MASAMUNE A, SUZUKI N, KIKUTA K, et al. Curcumin blocks activation of pancreatic stellate cells[J]. J Cell Biochem, 2006, 97(5):1080-1093. DOI:10.1002/jcb.20698 . |
| 40 | CECI C, TENTORI L, ATZORI M G, et al. Ellagic acid inhibits bladder cancer invasiveness and in vivo tumor growth[J]. Nutrients, 2016, 8(11):744. DOI:10.3390/nu8110744 . |
| 41 | ASAUMI H, WATANABE S, TAGUCHI M, et al. Green tea polyphenol (-)-epigallocatechin-3-gallate inhibits ethanol-induced activation of pancreatic stellate cells[J]. Eur J Clin Invest, 2006, 36(2):113-122. DOI:10.1111/j.1365-2362. 2006.01599.x . |
| 42 | SHEN K Z, FENG X W, SU R, et al. Epigallocatechin 3-gallate ameliorates bile duct ligation induced liver injury in mice by modulation of mitochondrial oxidative stress and inflammation[J]. PLoS One, 2015, 10(5):e0126278. DOI:10.1371/journal.pone.0126278 . |
| 43 | BHATT J K, THOMAS S, NANJAN M J. Resveratrol supplementation improves glycemic control in type 2 diabetes mellitus[J]. Nutr Res, 2012, 32(7):537-541. DOI: 10. 1016/j.nutres.2012.06.003 . |
| 44 | INCIO J, SUBOJ P, CHIN S M, et al. Metformin reduces desmoplasia in pancreatic cancer by reprogramming stellate cells and tumor-associated macrophages[J]. PLoS One, 2015, 10(12):e0141392. DOI: 10.1371/journal.pone.0141392 . |
| 45 | GUNDEWAR C, ANSARI D, TANG L G, et al. Antiproliferative effects of curcumin analog L49H37 in pancreatic stellate cells: a comparative study[J]. Ann Gastroenterol, 2015, 28(3):391-398. |
| [1] | LIU Yayi, JIA Yunfeng, ZUO Yiming, ZHANG Junping, LÜ Shichao. Progress and Evaluation of Animal Model of Heart Qi-Yin Deficiency Syndrome [J]. Laboratory Animal and Comparative Medicine, 2025, 45(4): 411-421. |
| [2] | ZHAO Xin, WANG Chenxi, SHI Wenqing, LOU Yuefen. Advances in the Application of Zebrafish in the Research of Inflammatory Bowel Disease Mechanisms and Drug Development [J]. Laboratory Animal and Comparative Medicine, 2025, 45(4): 422-431. |
| [3] | PAN Yicong, JIANG Wenhong, HU Ming, QIN Xiao. Optimization of Surgical Procedure and Efficacy Evaluation of Aortic Calcification Model in Rats with Chronic Kidney Disease [J]. Laboratory Animal and Comparative Medicine, 2025, 45(3): 279-289. |
| [4] | CHEN Yuhan, CHEN Jinling, LI Xin, OU Yanhua, WANG Si, CHEN Jingyi, WANG Xingyi, YUAN Jiali, DUAN Yuanyuan, YANG Zhongshan, NIU Haitao. Analysis of Animal Models of Myasthenia Gravis Based on Its Clinical Characteristics in Chinese and Western Medicine [J]. Laboratory Animal and Comparative Medicine, 2025, 45(2): 176-186. |
| [5] | LIAN Hui, JIANG Yanling, LIU Jia, ZHANG Yuli, XIE Wei, XUE Xiaoou, LI Jian. Construction and Evaluation of a Rat Model of Abnormal Uterine Bleeding [J]. Laboratory Animal and Comparative Medicine, 2025, 45(2): 130-146. |
| [6] | LUO Shixiong, ZHANG Sai, CHEN Hui. Research Progress in Establishment and Evaluation of Common Asthma Animal Models [J]. Laboratory Animal and Comparative Medicine, 2025, 45(2): 167-175. |
| [7] | WANG Biying, LU Jiashuo, ZAN Guiying, CHEN Ruosong, CHAI Jingrui, LIU Jinggen, WANG Yujun. Establishment Methods and Application Progress of Rodent Models for Drug Addiction [J]. Laboratory Animal and Comparative Medicine, 2025, 45(2): 158-166. |
| [8] | FEI Bin, GUO Wenke, GUO Jianping. Research Progress on Animal Models for Hernia Diseases and New Hernia Repair Materials [J]. Laboratory Animal and Comparative Medicine, 2025, 45(1): 55-66. |
| [9] | YANG Jiahao, DING Chunlei, QIAN Fenghua, SUN Qi, JIANG Xusheng, CHEN Wen, SHEN Mengwen. Research Progress on Animal Models of Sepsis-Related Organ Injury [J]. Laboratory Animal and Comparative Medicine, 2024, 44(6): 636-644. |
| [10] | SUN Xiaorong, SU Dan, GUI Wenjuan, CHEN Yue. Establishment and Evaluation of a Moderate-to-Severe Knee Osteoarthritis Model in Rats Induced by Surgery [J]. Laboratory Animal and Comparative Medicine, 2024, 44(6): 597-604. |
| [11] | TIAN Fang, PAN Bin, SHI Jiayi, XU Yanyi, LI Weihua. Advances in Development of PM2.5-Exposed Animal Models and Their Application in Reproductive Toxicity Research [J]. Laboratory Animal and Comparative Medicine, 2024, 44(6): 626-635. |
| [12] | ZHAO Xiaona, WANG Peng, YE Maoqing, QU Xinkai. Establishment of a New Hyperglycemic Obesity Cardiac Dysfunction Mouse Model with Triacsin C [J]. Laboratory Animal and Comparative Medicine, 2024, 44(6): 605-612. |
| [13] | TU Yingxin, JI Yilan, WANG Fei, YANG Dongming, WANG Dongdong, SUN Zhixin, DAI Yuexin, WANG Yanji, Guanghan KAN, WU Bin, ZHAO Deming, YANG Lifeng. Evaluation of Simulated Weightlessness Model of Hindlimb Unloading Miniature Pigs and Their Tissue Damage [J]. Laboratory Animal and Comparative Medicine, 2024, 44(5): 475-486. |
| [14] | HUANG Dongyan, WU Jianhui. Establishment Methods and Application Evaluation of Animal Models in Reproductive Toxicology Research [J]. Laboratory Animal and Comparative Medicine, 2024, 44(5): 550-559. |
| [15] | ZHENG Yiqing, DENG Yasheng, FAN Yanping, LIANG Tianwei, HUANG Hui, LIU Yonghui, NI Zhaobing, LIN Jiang. Application Analysis of Animal Models for Pelvic Inflammatory Disease Based on Data Mining [J]. Laboratory Animal and Comparative Medicine, 2024, 44(4): 405-418. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||